Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 2
2006 3
2007 2
2008 1
2009 5
2010 1
2011 5
2012 2
2013 2
2014 4
2015 5
2016 10
2017 6
2018 6
2019 2
2020 2
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Among authors: de franciscis v. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Free PMC article. Review.
Nucleic acids delivering nucleic acids.
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Catuogno S, et al. Among authors: de franciscis v. Adv Drug Deliv Rev. 2018 Sep;134:79-93. doi: 10.1016/j.addr.2018.04.006. Epub 2018 Apr 6. Adv Drug Deliv Rev. 2018. PMID: 29630917 Review.
Challenging cancer targets for aptamer delivery.
de Franciscis V. de Franciscis V. Biochimie. 2018 Feb;145:45-52. doi: 10.1016/j.biochi.2017.09.014. Epub 2017 Sep 28. Biochimie. 2018. PMID: 28962871 Review.
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.
Catuogno S, Esposito CL, de Franciscis V. Catuogno S, et al. Among authors: de franciscis v. Pharmaceuticals (Basel). 2016 Nov 3;9(4):69. doi: 10.3390/ph9040069. Pharmaceuticals (Basel). 2016. PMID: 27827876 Free PMC article. Review.
Cell-specific aptamers for targeted therapies.
Cerchia L, Giangrande PH, McNamara JO, de Franciscis V. Cerchia L, et al. Among authors: de franciscis v. Methods Mol Biol. 2009;535:59-78. doi: 10.1007/978-1-59745-557-2_5. Methods Mol Biol. 2009. PMID: 19377980 Free PMC article. Review.
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19.
Esposito CL, Van Roosbroeck K, Santamaria G, Rotoli D, Sandomenico A, Wierda WG, Ferrajoli A, Ruvo M, Calin GA, de Franciscis V, Catuogno S. Esposito CL, et al. Among authors: de franciscis v. Cancers (Basel). 2021 Oct 18;13(20):5220. doi: 10.3390/cancers13205220. Cancers (Basel). 2021. PMID: 34680368 Free PMC article.
Aptamers in Bordeaux, 24-25 June 2016.
Toulmé JJ, Giangrande PH, Mayer G, Suess B, Ducongé F, Sullenger B, de Franciscis V, Darfeuille F, Peyrin E. Toulmé JJ, et al. Among authors: de franciscis v. Pharmaceuticals (Basel). 2017 Jan 20;10(1):14. doi: 10.3390/ph10010014. Pharmaceuticals (Basel). 2017. PMID: 28117671 Free PMC article.
64 results